Lake Street analyst Brooks O’Neil lowered the firm’s price target on P3 Health Partners (PIII) to $20 from $50 and keeps a Buy rating on the ...

P3 Health Partners reported steady revenue growth and reaffirmed its profitability targets for 2025, supported by operational improvements and strategic contract renegotiations. While challenges ...

HENDERSON, Nev., April 02, 2025--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate ...

P3 Health Partners Inc. PIII shares soared 8.9% in the last trading session to close at $9.79. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

These companies largely earn their competitive advantage from intangible assets, and their stocks are great choices for an investor’s watchlist. We sell different types of products and services ...

19:50 EDT P3 Health Partners (PIII) Inc trading halted, news pending Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for ...

P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 24th Annual ...

Good day and welcome to the P3 Health Partners’ Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation ...

P3 Health Partners Inc. PIII shares soared 8.9% in the last trading session to close at $9.79. The move was backed by solid volume with far more shares changing hands than in a normal session.